Anticoagulant activity of dextran derivatives

Journal of Biomedical Materials Research

Volumn 41, Issue 1, 1998, Pages 49-57

  De Raucourt, E ^a   Mauray, S ^a   Chaubet, F ^b   Maiga Revel, O ^b   Jozefowicz, M ^b   Fischer, A M ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

Anticoagulant; CMDBS; Dextran derivatives; Heparin cofactor II; Thrombin

Indexed keywords

BLOOD VESSELS; CARDIOLOGY; ENZYMES; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

ANTICOAGULANTS; SULFATES;

POLYSACCHARIDES;

ANTICOAGULANT AGENT; ANTITHROMBIN; CARBOXYMETHYL DEXTRAN BENZYLAMIDE SULFONATE; DEXTRAN; DEXTRAN SULFATE; HEPARIN COFACTOR II; THROMBIN; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; BINDING AFFINITY; CATALYSIS; ENZYME ACTIVE SITE; ENZYME KINETICS; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; THERMODYNAMICS; THROMBIN TIME;

ANTICOAGULANTS; CATALYSIS; DEXTRANS; HEPARIN COFACTOR II; HUMANS; KINETICS; THERMODYNAMICS; THROMBIN;

EID: 0032126417     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199807)41:1<49::AID-JBM6>3.0.CO;2-Q     Document Type: Article

References (28)

1. J. W. Fenton, F. A. Ofosu, D. G. Moon, and J. M. Maraganore, "Thrombin structure and function: Why thrombin is the primary target for antithrombics," Blood Coagul. Fibrinolysis, 2, 69-75 (1991).
2. D. M. Tollefsen, W. M. Majerus, and M. K. Blank, "Heparin cofactor II," J. Biol. Chem., 257, 2162-2169 (1982).
3. C. W. Pratt, H. C. Whinna, J. B. Meade, R. E. Treanor, and F. C. Church, "Physicochemical aspects of heparin cofactor II," Ann. NY Acad. Sci., 556, 104-115 (1989).
4. R. D. Rosenberg and P. S. Damus, "Purification and mechanism of action of human thrombin-heparin cofactor," J. Biol. Chem., 18, 6490-6505 (1973).
5. M. C. Bourin and U. Lindahl, "Glycosaminoglycans and regulation of blood coagulation," Biochem. J., 28, 313-330 (1993).
6. B. H. Chong, "Heparin-induced thrombocytopenia," Br. J. Haematol., 89, 431-139 (1995).
7. M. Mauzac and J. Jozefonvicz, "Anticoagulant activity of dextran derivatives. I. Synthesis and characterization," Biomaterials, 5, 301-304 (1984).
8. F. Chaubet, J. Champion, O. Maîga, S. Mauray, and J. Jozefonvicz, "Synthesis and structure-anticoagulant property relationships of functionalized dextrans: CMDBS," Carbohydrate Polym., 28, 145-152 (1995).
9. B. Crepon, F. Maillet, M. D. Kazatchkine, and J. Jozefonvicz, "Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans," Biomaterials, 8, 248-253 (1987).
10. A. Bezeaud, M. H. Denninger, and M. C. Guillin, "Interaction of human α-thrombin and γ-thrombin with antithrombin III, protein C and thrombomodulin," Eur. J. Biochem., 153, 491-496 (1985).
11. K. Nagasawa, Y. Inoue, and T. Kamato, "Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl sulfoxide containing water or methanol," Carbohydrate Res., 58, 47-55 (1997).
12. R. Jordan, D. Beeler, and R. D. Rosenberg, "Fractionation of low molecular weight heparin species and their interaction with antithrombin," J. Biol. Chem., 254, 2902-2913 (1979).
13. R. M. Maaroufi, J. Tapon-Bretaudière, M. Jozefonvicz, and A. M. Fischer, "Mechanism of thrombin inhibition by antithrombin and heparin cofactor II in the presence of heparin," Biomaterials, 18, 203-211 (1997).
14. R. M. Maaroufi, M. Jozefowicz, J. Tapon-Bretaudière, J. Jozefonvicz, and A. M. Fischer, "Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and heparin-like dextran derivative," Biomaterials, 18, 359-366 (1997).
15. S. Alban and G. Franz, "Gas-liquid chromatography-mass spectrometry analysis of anticoagulant active curdlan sulfates," Sem. Thromb. Haemost., 20, 152-158 (1994).
16. T. Nishino, Y. Aizu, and T. Nagumo, "The influence of sulfate content and molecular weight of a fucan sulfate from brown seaweed Ecklonia kurome," Thromb. Res., 64, 723-731 (1991).
17. R. M. Maaroufi, J. Tapon-Bretaudière, J. Mardiguian, C. Sternberg, M. D. Dautzenberg, and A. M. Fischer, "Influence of the oversulfation method and the degree of sulfation on the anticoagulant properties of dermatan sulfate derivatives," Thromb. Res., 59, 749-758 (1990).
18. S. Mauray, E. de Raucourt, J. Champion, C. Sternberg, F. Chaubet, and A. M. Fischer, "Le CMDBS: Un nouveau polysaccharide anticoagulant," [abstract], GEHT-PARIS 20-21 octobre 1995.
19. P. Sie, F. Ofosu, F. Fernandez, M. R. Buchanan, M. Petitou, and B. Boneu, "Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and various sulphated polysaccharides," Br. J. Haematol., 64, 707-714 (1986).
20. G. Oshima, T. Nagai, and K. Nagasawa, "Abolition by dextran sulfate of the heparin-accelerated antithrombin III/thrombin reaction," Thromb. Res., 35, 601-611 (1984).
21. R. Yamagashi, M. Niwa, and N. Sakuragawa, "Thrombin inhibitory activity of heparin cofactor n depends on the molecular weight and sulfate amount of dextran sulfate," Thromb. Res., 44, 347-354 (1986).
22. F. M. Tollefsen, C. A. Pestka, and W. J. Monafo, "Activation of heparin cofactor II by dermatan sulfate," J. Biol. Chem., 258, 6713-6716 (1983).
23. S. Mauray, E. de Raucourt, J. Dachary-Prigent, J. C. Talbot, M. Jozefowicz, and A. M. Fischer, "Mechanism of the catalytic effect of several sulfated polysaccharides on Factor IX inhibition," [abstract], in Second Meeting of the European Haematology Association, Paris, Br. J. Haematol., 93(Suppl. 2), 172 (1996).
24. V. M. D. Van Deerlin and M. D. Tollefsen, "The N-terminal acidic domain of heparin cofactor II mediates the inhibition of α-thrombin in the presence of glycosaminoglycans," J. Biol. Chem., 266, 20223-20231 (1991).
25. D. M. Tollefsen, "Insight into the mechanism of action of heparin cofactor II," Thromb. Haemost., 74, 1209-1214 (1995).
26. Y. Hayakawa, T. Hayashi, K. Hayashi, T. Hayashi, T. Ozawa, K. Niiya, and N. Sakuragawa, "Heparin cofactor II-dependent antithrombin activity of calcium spirulan," Blood Coagul. Fibrinolysis, 7, 554-560 (1996).
27. M. T. Stubbs and W. Bode, "The clot thickens: Clues provided by thrombin structure," TIBS, 20, 23-28 (1995).
28. W. Bode, D. Turk, and A. Karshikov, "The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: Structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships," Protein Sci., 1, 426-471 (1992).